Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.93024652 |
2 | synaptic vesicle exocytosis (GO:0016079) | 5.70116290 |
3 | vocalization behavior (GO:0071625) | 5.36576026 |
4 | nucleotide transmembrane transport (GO:1901679) | 5.29412923 |
5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.25526409 |
6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.24839220 |
7 | nucleoside transmembrane transport (GO:1901642) | 5.20284043 |
8 | adenine nucleotide transport (GO:0051503) | 5.13715510 |
9 | glutamate secretion (GO:0014047) | 5.13134969 |
10 | purine ribonucleotide transport (GO:0015868) | 5.09457666 |
11 | protein localization to synapse (GO:0035418) | 5.08616207 |
12 | heme transport (GO:0015886) | 5.03192697 |
13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.88442764 |
14 | neuron cell-cell adhesion (GO:0007158) | 4.87427812 |
15 | neuronal action potential propagation (GO:0019227) | 4.87110249 |
16 | synaptic vesicle maturation (GO:0016188) | 4.86987848 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.86899370 |
18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.83038229 |
19 | locomotory exploration behavior (GO:0035641) | 4.79688324 |
20 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.78099542 |
21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.73880125 |
22 | organic cation transport (GO:0015695) | 4.71250445 |
23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.70504182 |
24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.67774012 |
25 | iron coordination entity transport (GO:1901678) | 4.48451457 |
26 | glutamate receptor signaling pathway (GO:0007215) | 4.41868594 |
27 | neuron-neuron synaptic transmission (GO:0007270) | 4.35004867 |
28 | regulation of synaptic vesicle transport (GO:1902803) | 4.34957374 |
29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.29876345 |
30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.27478826 |
31 | ATP synthesis coupled proton transport (GO:0015986) | 4.27478826 |
32 | synaptic transmission, glutamatergic (GO:0035249) | 4.21156472 |
33 | exploration behavior (GO:0035640) | 4.20509422 |
34 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.16549096 |
35 | cofactor transport (GO:0051181) | 4.13816426 |
36 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.11032858 |
37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.10431451 |
38 | * neurotransmitter secretion (GO:0007269) | 4.09261046 |
39 | chaperone-mediated protein transport (GO:0072321) | 4.06122180 |
40 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.05076083 |
41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.04033342 |
42 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.00874444 |
43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.97215527 |
44 | purine nucleotide transport (GO:0015865) | 3.96437170 |
45 | presynaptic membrane assembly (GO:0097105) | 3.94117532 |
46 | regulation of glutamate secretion (GO:0014048) | 3.91594025 |
47 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.91539746 |
48 | long-term synaptic potentiation (GO:0060291) | 3.90101431 |
49 | behavioral response to nicotine (GO:0035095) | 3.89735366 |
50 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.87970619 |
51 | glycerophospholipid catabolic process (GO:0046475) | 3.87097093 |
52 | negative regulation of type 2 immune response (GO:0002829) | 3.87036829 |
53 | neuron recognition (GO:0008038) | 3.85582225 |
54 | protein K6-linked ubiquitination (GO:0085020) | 3.82390641 |
55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81167908 |
56 | negative regulation of telomerase activity (GO:0051974) | 3.78816521 |
57 | positive regulation of synapse maturation (GO:0090129) | 3.77132959 |
58 | negative regulation of telomere maintenance (GO:0032205) | 3.74086075 |
59 | synapsis (GO:0007129) | 3.73779748 |
60 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.72764495 |
61 | regulation of synaptic plasticity (GO:0048167) | 3.72342751 |
62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.70645368 |
63 | presynaptic membrane organization (GO:0097090) | 3.69516278 |
64 | positive regulation of membrane potential (GO:0045838) | 3.68937203 |
65 | long-term memory (GO:0007616) | 3.63344803 |
66 | behavioral response to cocaine (GO:0048148) | 3.63259584 |
67 | synaptic vesicle endocytosis (GO:0048488) | 3.61983444 |
68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54780156 |
69 | postsynaptic membrane organization (GO:0001941) | 3.53987905 |
70 | regulation of vesicle fusion (GO:0031338) | 3.53249025 |
71 | response to histamine (GO:0034776) | 3.52619507 |
72 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.49479465 |
73 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.47488390 |
74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46345537 |
75 | regulation of synapse structural plasticity (GO:0051823) | 3.45978517 |
76 | male meiosis I (GO:0007141) | 3.45835802 |
77 | regulation of feeding behavior (GO:0060259) | 3.42272799 |
78 | behavioral defense response (GO:0002209) | 3.41330284 |
79 | behavioral fear response (GO:0001662) | 3.41330284 |
80 | protein neddylation (GO:0045116) | 3.40209876 |
81 | establishment of nucleus localization (GO:0040023) | 3.39701623 |
82 | * neurotransmitter transport (GO:0006836) | 3.39056022 |
83 | negative regulation of amino acid transport (GO:0051956) | 3.36170692 |
84 | fear response (GO:0042596) | 3.33315125 |
85 | regulation of neurotransmitter secretion (GO:0046928) | 3.32748772 |
86 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.32626661 |
87 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.32626661 |
88 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.32577502 |
89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.32435579 |
90 | axonal fasciculation (GO:0007413) | 3.32057880 |
91 | nucleoside transport (GO:0015858) | 3.31582685 |
92 | nucleobase catabolic process (GO:0046113) | 3.29920867 |
93 | synaptic transmission, dopaminergic (GO:0001963) | 3.27771820 |
94 | transmission of nerve impulse (GO:0019226) | 3.26804143 |
95 | proline transport (GO:0015824) | 3.26611752 |
96 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.25748695 |
97 | piRNA metabolic process (GO:0034587) | 3.24001282 |
98 | dendritic spine morphogenesis (GO:0060997) | 3.22074584 |
99 | serotonin metabolic process (GO:0042428) | 3.19205197 |
100 | telomere maintenance via telomerase (GO:0007004) | 3.19085525 |
101 | folic acid transport (GO:0015884) | 3.19054357 |
102 | membrane depolarization (GO:0051899) | 3.17381824 |
103 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.17216841 |
104 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.16816881 |
105 | * regulation of neurotransmitter levels (GO:0001505) | 3.16617545 |
106 | gamma-aminobutyric acid transport (GO:0015812) | 3.15831745 |
107 | activation of protein kinase A activity (GO:0034199) | 3.14599983 |
108 | detection of calcium ion (GO:0005513) | 3.14400293 |
109 | startle response (GO:0001964) | 3.13040575 |
110 | regulation of dendritic spine development (GO:0060998) | 3.11948487 |
111 | transferrin transport (GO:0033572) | 3.10214407 |
112 | layer formation in cerebral cortex (GO:0021819) | 3.08420129 |
113 | learning (GO:0007612) | 3.08094768 |
114 | neuromuscular process controlling posture (GO:0050884) | 3.07991149 |
115 | synaptic transmission (GO:0007268) | 3.05953152 |
116 | cellular potassium ion homeostasis (GO:0030007) | 3.05659090 |
117 | regulation of female receptivity (GO:0045924) | 3.04845003 |
118 | regulation of neurotransmitter transport (GO:0051588) | 3.04504882 |
119 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04226732 |
120 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.02660689 |
121 | long term synaptic depression (GO:0060292) | 3.02597654 |
122 | regulation of synaptic transmission (GO:0050804) | 3.02396106 |
123 | positive regulation of synaptic transmission (GO:0050806) | 3.01925769 |
124 | regulation of telomerase activity (GO:0051972) | 3.01140503 |
125 | innervation (GO:0060384) | 3.00917304 |
126 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.00463188 |
127 | female mating behavior (GO:0060180) | 3.00154830 |
128 | response to pheromone (GO:0019236) | 2.99715272 |
129 | regulation of neurotransmitter uptake (GO:0051580) | 2.98596947 |
130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97746200 |
131 | establishment of synaptic vesicle localization (GO:0097480) | 2.96519956 |
132 | synaptic vesicle transport (GO:0048489) | 2.96519956 |
133 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.96503830 |
134 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.96503830 |
135 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.96422346 |
136 | protein polyglutamylation (GO:0018095) | 2.95764056 |
137 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94922421 |
138 | regulation of synapse maturation (GO:0090128) | 2.94877739 |
139 | membrane hyperpolarization (GO:0060081) | 2.94156707 |
140 | inositol phosphate catabolic process (GO:0071545) | 2.93969793 |
141 | negative regulation of dendrite development (GO:2000171) | 2.93646087 |
142 | protein complex biogenesis (GO:0070271) | 2.92236001 |
143 | regulation of protein kinase A signaling (GO:0010738) | 2.91817183 |
144 | membrane depolarization during action potential (GO:0086010) | 2.91159994 |
145 | negative regulation of multicellular organism growth (GO:0040015) | 2.81540267 |
146 | cell migration in hindbrain (GO:0021535) | 2.80231708 |
147 | ATP biosynthetic process (GO:0006754) | 2.78846518 |
148 | cornea development in camera-type eye (GO:0061303) | 2.74823715 |
149 | protein localization to cilium (GO:0061512) | 2.74566223 |
150 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.70159870 |
151 | retinal cone cell development (GO:0046549) | 2.69087634 |
152 | neuron remodeling (GO:0016322) | 2.67777233 |
153 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.66726202 |
154 | NADH dehydrogenase complex assembly (GO:0010257) | 2.66726202 |
155 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.66726202 |
156 | nucleotide transport (GO:0006862) | 2.66478183 |
157 | brain morphogenesis (GO:0048854) | 2.66092189 |
158 | axoneme assembly (GO:0035082) | 2.64091365 |
159 | regulation of cilium movement (GO:0003352) | 2.62905908 |
160 | electron transport chain (GO:0022900) | 2.62847861 |
161 | regulation of microtubule-based movement (GO:0060632) | 2.62228410 |
162 | surfactant homeostasis (GO:0043129) | 2.61807794 |
163 | parturition (GO:0007567) | 2.60753653 |
164 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.59104452 |
165 | respiratory electron transport chain (GO:0022904) | 2.58838472 |
166 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.57956835 |
167 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.56233957 |
168 | metallo-sulfur cluster assembly (GO:0031163) | 2.56166492 |
169 | iron-sulfur cluster assembly (GO:0016226) | 2.56166492 |
170 | cellular ketone body metabolic process (GO:0046950) | 2.53539996 |
171 | inositol phosphate dephosphorylation (GO:0046855) | 2.53251297 |
172 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.53251297 |
173 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.51369939 |
174 | regulation of action potential (GO:0098900) | 2.50928825 |
175 | DNA methylation involved in gamete generation (GO:0043046) | 2.50386237 |
176 | meiosis I (GO:0007127) | 2.48958793 |
177 | collecting duct development (GO:0072044) | 2.46916728 |
178 | striatum development (GO:0021756) | 2.46072664 |
179 | neuronal action potential (GO:0019228) | 2.44898316 |
180 | detection of light stimulus involved in visual perception (GO:0050908) | 2.43414748 |
181 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.43414748 |
182 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.41688924 |
183 | positive regulation of meiosis (GO:0045836) | 2.41283417 |
184 | protein deneddylation (GO:0000338) | 2.41162039 |
185 | nonmotile primary cilium assembly (GO:0035058) | 2.40608755 |
186 | polarized epithelial cell differentiation (GO:0030859) | 2.39975709 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.26479700 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.21541355 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.89667299 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.34537588 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.22661950 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18456028 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83907285 |
8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.82968538 |
9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.80914226 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74331940 |
11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71042317 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71042317 |
13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.63447012 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.60316256 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59394817 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58368145 |
17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53740815 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52490997 |
19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.39830087 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34824809 |
21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32865650 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25269110 |
23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.20277768 |
24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18784436 |
25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16642221 |
26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16567378 |
27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15542009 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.14244685 |
29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13867339 |
30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.11530254 |
31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08580428 |
32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91325943 |
33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89095737 |
34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80407974 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78945273 |
36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75216341 |
37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.73342075 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71101807 |
39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67236668 |
40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.63568128 |
41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62259511 |
42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62128839 |
43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.62011337 |
44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53357761 |
45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52617998 |
46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50477300 |
47 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50048441 |
48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48203765 |
49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47600395 |
50 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.47560282 |
51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47491617 |
52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46488895 |
53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45893852 |
54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42027519 |
55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40755957 |
56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38319401 |
57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38230575 |
58 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.37990504 |
59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37238719 |
60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35822037 |
61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35096583 |
62 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32021782 |
63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29068120 |
64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27731606 |
65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25218830 |
66 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.23958180 |
67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23591454 |
68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23515018 |
69 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22856766 |
70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22130175 |
71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22041226 |
72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21584503 |
73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20605503 |
74 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.20209014 |
75 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.20001301 |
76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19430125 |
77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18446247 |
78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18125173 |
79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17510591 |
80 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17321758 |
81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17321758 |
82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17302844 |
83 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16499638 |
84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15976576 |
85 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.15201023 |
86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14982510 |
87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14195664 |
88 | ERA_21632823_ChIP-Seq_H3396_Human | 1.14066599 |
89 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12911421 |
90 | JUN_21703547_ChIP-Seq_K562_Human | 1.11125088 |
91 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.09136801 |
92 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08616457 |
93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08143559 |
94 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08125886 |
95 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06851181 |
96 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.06753072 |
97 | AR_19668381_ChIP-Seq_PC3_Human | 1.06595341 |
98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05766467 |
99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04935311 |
100 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.04719398 |
101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04355434 |
102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03633573 |
103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03388063 |
104 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03111626 |
105 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02373405 |
106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02243136 |
107 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02222309 |
108 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02222309 |
109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01503099 |
110 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01503099 |
111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00884117 |
112 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99909837 |
113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99001797 |
114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98840981 |
115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98613150 |
116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97965818 |
117 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97877888 |
118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97663632 |
119 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97223222 |
120 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96680990 |
121 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96640725 |
122 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96264611 |
123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96081359 |
124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96072154 |
125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94978831 |
126 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.94719343 |
127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94692269 |
128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93838932 |
129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93838932 |
130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93341852 |
131 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.93301300 |
132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92898361 |
133 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92837479 |
134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92764315 |
135 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92348638 |
136 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91661812 |
137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90588268 |
138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90354361 |
139 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88262686 |
140 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85585753 |
141 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.84590222 |
142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83996021 |
143 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83671657 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 6.25287681 |
2 | MP0004859_abnormal_synaptic_plasticity | 6.15125593 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.17031539 |
4 | MP0009745_abnormal_behavioral_response | 3.59172039 |
5 | MP0002653_abnormal_ependyma_morphology | 3.52744644 |
6 | MP0004270_analgesia | 3.46618662 |
7 | MP0002063_abnormal_learning/memory/cond | 3.39735126 |
8 | MP0003011_delayed_dark_adaptation | 3.32362600 |
9 | MP0002064_seizures | 3.27756955 |
10 | MP0001968_abnormal_touch/_nociception | 3.11815368 |
11 | MP0009046_muscle_twitch | 3.07562808 |
12 | MP0002572_abnormal_emotion/affect_behav | 2.96141563 |
13 | MP0008877_abnormal_DNA_methylation | 2.77063634 |
14 | MP0002822_catalepsy | 2.76174779 |
15 | MP0002272_abnormal_nervous_system | 2.70647070 |
16 | MP0002736_abnormal_nociception_after | 2.67651347 |
17 | MP0004782_abnormal_surfactant_physiolog | 2.62411295 |
18 | MP0001501_abnormal_sleep_pattern | 2.60362711 |
19 | MP0005423_abnormal_somatic_nervous | 2.48553296 |
20 | MP0001486_abnormal_startle_reflex | 2.44973906 |
21 | MP0002734_abnormal_mechanical_nocicepti | 2.40003717 |
22 | MP0002735_abnormal_chemical_nociception | 2.39921032 |
23 | MP0001440_abnormal_grooming_behavior | 2.37866309 |
24 | MP0006276_abnormal_autonomic_nervous | 2.16449774 |
25 | MP0002733_abnormal_thermal_nociception | 2.01974199 |
26 | MP0002067_abnormal_sensory_capabilities | 2.01121625 |
27 | MP0001970_abnormal_pain_threshold | 1.94258144 |
28 | MP0001529_abnormal_vocalization | 1.88256709 |
29 | MP0003195_calcinosis | 1.88217740 |
30 | MP0003329_amyloid_beta_deposits | 1.77792675 |
31 | MP0002184_abnormal_innervation | 1.76153063 |
32 | MP0004924_abnormal_behavior | 1.73454638 |
33 | MP0005386_behavior/neurological_phenoty | 1.73454638 |
34 | MP0009780_abnormal_chondrocyte_physiolo | 1.72805024 |
35 | MP0003879_abnormal_hair_cell | 1.71882154 |
36 | MP0002837_dystrophic_cardiac_calcinosis | 1.71097994 |
37 | MP0002557_abnormal_social/conspecific_i | 1.68666465 |
38 | MP0002332_abnormal_exercise_endurance | 1.68229791 |
39 | MP0002102_abnormal_ear_morphology | 1.68184388 |
40 | MP0001905_abnormal_dopamine_level | 1.67587038 |
41 | MP0001984_abnormal_olfaction | 1.64360497 |
42 | MP0000778_abnormal_nervous_system | 1.63460698 |
43 | MP0004142_abnormal_muscle_tone | 1.59781425 |
44 | MP0005646_abnormal_pituitary_gland | 1.57392166 |
45 | MP0003787_abnormal_imprinting | 1.55633419 |
46 | MP0008569_lethality_at_weaning | 1.54062036 |
47 | MP0004811_abnormal_neuron_physiology | 1.53934776 |
48 | MP0002909_abnormal_adrenal_gland | 1.49998695 |
49 | MP0003646_muscle_fatigue | 1.49048951 |
50 | MP0003122_maternal_imprinting | 1.45260747 |
51 | MP0000955_abnormal_spinal_cord | 1.42945050 |
52 | MP0004858_abnormal_nervous_system | 1.41231372 |
53 | MP0002066_abnormal_motor_capabilities/c | 1.37651242 |
54 | MP0001188_hyperpigmentation | 1.36693637 |
55 | MP0005253_abnormal_eye_physiology | 1.36562073 |
56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35442976 |
57 | MP0003136_yellow_coat_color | 1.32719167 |
58 | MP0001502_abnormal_circadian_rhythm | 1.31583693 |
59 | MP0002882_abnormal_neuron_morphology | 1.31393854 |
60 | MP0003121_genomic_imprinting | 1.28965570 |
61 | MP0002160_abnormal_reproductive_system | 1.23353357 |
62 | MP0005084_abnormal_gallbladder_morpholo | 1.21321197 |
63 | MP0008789_abnormal_olfactory_epithelium | 1.16941455 |
64 | MP0006292_abnormal_olfactory_placode | 1.16133674 |
65 | MP0003633_abnormal_nervous_system | 1.15413660 |
66 | MP0000751_myopathy | 1.14413092 |
67 | MP0002876_abnormal_thyroid_physiology | 1.04835600 |
68 | MP0004147_increased_porphyrin_level | 1.04273369 |
69 | MP0008872_abnormal_physiological_respon | 1.03082155 |
70 | MP0003631_nervous_system_phenotype | 1.00636448 |
71 | MP0010386_abnormal_urinary_bladder | 0.99516183 |
72 | MP0005389_reproductive_system_phenotype | 0.98740521 |
73 | MP0005535_abnormal_body_temperature | 0.97746549 |
74 | MP0005645_abnormal_hypothalamus_physiol | 0.97031329 |
75 | MP0006036_abnormal_mitochondrial_physio | 0.96038386 |
76 | MP0002152_abnormal_brain_morphology | 0.95996503 |
77 | MP0000013_abnormal_adipose_tissue | 0.95928441 |
78 | MP0000566_synostosis | 0.95743698 |
79 | MP0002229_neurodegeneration | 0.92110664 |
80 | MP0004885_abnormal_endolymph | 0.92063875 |
81 | MP0008874_decreased_physiological_sensi | 0.91642028 |
82 | MP0004145_abnormal_muscle_electrophysio | 0.91403535 |
83 | MP0002069_abnormal_eating/drinking_beha | 0.90756544 |
84 | MP0004742_abnormal_vestibular_system | 0.90401115 |
85 | MP0005551_abnormal_eye_electrophysiolog | 0.89068718 |
86 | MP0000427_abnormal_hair_cycle | 0.88129867 |
87 | MP0004085_abnormal_heartbeat | 0.87724459 |
88 | MP0001963_abnormal_hearing_physiology | 0.86739967 |
89 | MP0002163_abnormal_gland_morphology | 0.82467277 |
90 | MP0004484_altered_response_of | 0.81230187 |
91 | MP0003890_abnormal_embryonic-extraembry | 0.80710892 |
92 | MP0003698_abnormal_male_reproductive | 0.80645734 |
93 | MP0000049_abnormal_middle_ear | 0.80224527 |
94 | MP0000604_amyloidosis | 0.79453040 |
95 | MP0004215_abnormal_myocardial_fiber | 0.78973451 |
96 | MP0005332_abnormal_amino_acid | 0.78801828 |
97 | MP0005195_abnormal_posterior_eye | 0.78492041 |
98 | MP0005085_abnormal_gallbladder_physiolo | 0.77341938 |
99 | MP0000372_irregular_coat_pigmentation | 0.76730459 |
100 | MP0005266_abnormal_metabolism | 0.76683352 |
101 | MP0004133_heterotaxia | 0.75419981 |
102 | MP0001664_abnormal_digestion | 0.75200879 |
103 | MP0001293_anophthalmia | 0.75065188 |
104 | MP0005409_darkened_coat_color | 0.73399657 |
105 | MP0002210_abnormal_sex_determination | 0.73138791 |
106 | MP0002752_abnormal_somatic_nervous | 0.71871136 |
107 | MP0005394_taste/olfaction_phenotype | 0.70582468 |
108 | MP0005499_abnormal_olfactory_system | 0.70582468 |
109 | MP0000631_abnormal_neuroendocrine_gland | 0.65030371 |
110 | MP0001485_abnormal_pinna_reflex | 0.64890890 |
111 | MP0003632_abnormal_nervous_system | 0.64527466 |
112 | MP0005171_absent_coat_pigmentation | 0.63246312 |
113 | MP0001177_atelectasis | 0.62420348 |
114 | MP0003634_abnormal_glial_cell | 0.61873407 |
115 | MP0003075_altered_response_to | 0.61267197 |
116 | MP0005623_abnormal_meninges_morphology | 0.59244054 |
117 | MP0001986_abnormal_taste_sensitivity | 0.57019801 |
118 | MP0001765_abnormal_ion_homeostasis | 0.56687164 |
119 | MP0004233_abnormal_muscle_weight | 0.55925225 |
120 | MP0001943_abnormal_respiration | 0.55164376 |
121 | MP0002090_abnormal_vision | 0.54489349 |
122 | MP0000026_abnormal_inner_ear | 0.54009290 |
123 | MP0002638_abnormal_pupillary_reflex | 0.52668896 |
124 | MP0005379_endocrine/exocrine_gland_phen | 0.50038017 |
125 | MP0006035_abnormal_mitochondrial_morpho | 0.49084277 |
126 | MP0003137_abnormal_impulse_conducting | 0.49068595 |
127 | MP0003123_paternal_imprinting | 0.48694775 |
128 | MP0003956_abnormal_body_size | 0.48330428 |
129 | MP0000920_abnormal_myelination | 0.47931392 |
130 | MP0006072_abnormal_retinal_apoptosis | 0.46972209 |
131 | MP0004043_abnormal_pH_regulation | 0.46365998 |
132 | MP0010234_abnormal_vibrissa_follicle | 0.44962493 |
133 | MP0010769_abnormal_survival | 0.44520255 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.77040001 |
2 | Myokymia (HP:0002411) | 6.75215831 |
3 | Focal seizures (HP:0007359) | 6.01376655 |
4 | Atonic seizures (HP:0010819) | 5.92901586 |
5 | Epileptic encephalopathy (HP:0200134) | 5.63513263 |
6 | Visual hallucinations (HP:0002367) | 5.46524256 |
7 | Febrile seizures (HP:0002373) | 5.04794779 |
8 | Absence seizures (HP:0002121) | 4.87101039 |
9 | Dialeptic seizures (HP:0011146) | 4.45870474 |
10 | Hyperventilation (HP:0002883) | 4.28915204 |
11 | Progressive cerebellar ataxia (HP:0002073) | 4.12068549 |
12 | Generalized tonic-clonic seizures (HP:0002069) | 4.08621899 |
13 | Amblyopia (HP:0000646) | 3.74139136 |
14 | Molar tooth sign on MRI (HP:0002419) | 3.52587626 |
15 | Abnormality of midbrain morphology (HP:0002418) | 3.52587626 |
16 | Congenital stationary night blindness (HP:0007642) | 3.50067415 |
17 | Broad-based gait (HP:0002136) | 3.48109005 |
18 | Supranuclear gaze palsy (HP:0000605) | 3.21413710 |
19 | Poor eye contact (HP:0000817) | 3.21142199 |
20 | Abnormality of the labia minora (HP:0012880) | 3.14936832 |
21 | Gaze-evoked nystagmus (HP:0000640) | 3.13766923 |
22 | Chronic hepatic failure (HP:0100626) | 3.08087821 |
23 | Retinal dysplasia (HP:0007973) | 3.07694146 |
24 | Anxiety (HP:0000739) | 3.02578992 |
25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.01937239 |
26 | Action tremor (HP:0002345) | 2.96247414 |
27 | Acute necrotizing encephalopathy (HP:0006965) | 2.96153993 |
28 | Dysdiadochokinesis (HP:0002075) | 2.95927473 |
29 | Epileptiform EEG discharges (HP:0011182) | 2.86645604 |
30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86273193 |
31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86273193 |
32 | Dysmetria (HP:0001310) | 2.86121581 |
33 | Impaired social interactions (HP:0000735) | 2.85549702 |
34 | Abnormal social behavior (HP:0012433) | 2.85549702 |
35 | Pancreatic fibrosis (HP:0100732) | 2.85027487 |
36 | True hermaphroditism (HP:0010459) | 2.84755873 |
37 | Abnormal eating behavior (HP:0100738) | 2.80297606 |
38 | Pancreatic cysts (HP:0001737) | 2.79538668 |
39 | Truncal ataxia (HP:0002078) | 2.78845670 |
40 | Large for gestational age (HP:0001520) | 2.75840524 |
41 | Depression (HP:0000716) | 2.74132883 |
42 | Cerebral inclusion bodies (HP:0100314) | 2.73988324 |
43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.72909844 |
44 | Excessive salivation (HP:0003781) | 2.65752387 |
45 | Drooling (HP:0002307) | 2.65752387 |
46 | Progressive macrocephaly (HP:0004481) | 2.65486352 |
47 | Dyskinesia (HP:0100660) | 2.65319440 |
48 | Delusions (HP:0000746) | 2.62537217 |
49 | Nephronophthisis (HP:0000090) | 2.62401037 |
50 | Type II lissencephaly (HP:0007260) | 2.61381571 |
51 | EEG with generalized epileptiform discharges (HP:0011198) | 2.58036008 |
52 | Progressive inability to walk (HP:0002505) | 2.55740743 |
53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.54676951 |
54 | Rib fusion (HP:0000902) | 2.54333056 |
55 | Lissencephaly (HP:0001339) | 2.52431944 |
56 | Abnormality of the lower motor neuron (HP:0002366) | 2.49970155 |
57 | Ankle clonus (HP:0011448) | 2.48254889 |
58 | Pheochromocytoma (HP:0002666) | 2.48242178 |
59 | Inability to walk (HP:0002540) | 2.47990419 |
60 | Hepatic necrosis (HP:0002605) | 2.42420735 |
61 | Limb dystonia (HP:0002451) | 2.41495248 |
62 | Agitation (HP:0000713) | 2.41410927 |
63 | Mitochondrial inheritance (HP:0001427) | 2.40831917 |
64 | Sclerocornea (HP:0000647) | 2.39101895 |
65 | Abnormality of the renal cortex (HP:0011035) | 2.38305359 |
66 | Status epilepticus (HP:0002133) | 2.38155366 |
67 | Increased hepatocellular lipid droplets (HP:0006565) | 2.36812691 |
68 | Polyphagia (HP:0002591) | 2.36523072 |
69 | Hypsarrhythmia (HP:0002521) | 2.36259560 |
70 | Pachygyria (HP:0001302) | 2.34997368 |
71 | Renal cortical cysts (HP:0000803) | 2.33723473 |
72 | Cheilitis (HP:0100825) | 2.32527888 |
73 | Bradykinesia (HP:0002067) | 2.32352489 |
74 | Scanning speech (HP:0002168) | 2.27899325 |
75 | Generalized myoclonic seizures (HP:0002123) | 2.27715799 |
76 | Neuroendocrine neoplasm (HP:0100634) | 2.27632062 |
77 | Abnormality of macular pigmentation (HP:0008002) | 2.26339231 |
78 | Fetal akinesia sequence (HP:0001989) | 2.26182255 |
79 | Termporal pattern (HP:0011008) | 2.25387977 |
80 | Insidious onset (HP:0003587) | 2.25387977 |
81 | Stereotypic behavior (HP:0000733) | 2.23843591 |
82 | Absent speech (HP:0001344) | 2.22776763 |
83 | Impaired smooth pursuit (HP:0007772) | 2.22256871 |
84 | Postural instability (HP:0002172) | 2.22245965 |
85 | Acute encephalopathy (HP:0006846) | 2.22108554 |
86 | Focal dystonia (HP:0004373) | 2.21357069 |
87 | Torticollis (HP:0000473) | 2.20221444 |
88 | Poor suck (HP:0002033) | 2.18523922 |
89 | Abnormality of binocular vision (HP:0011514) | 2.18085097 |
90 | Diplopia (HP:0000651) | 2.18085097 |
91 | Abnormal hair whorl (HP:0010721) | 2.17789259 |
92 | Decreased circulating renin level (HP:0003351) | 2.16428830 |
93 | Gait imbalance (HP:0002141) | 2.15942731 |
94 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14474939 |
95 | Hemiparesis (HP:0001269) | 2.12926948 |
96 | Urinary urgency (HP:0000012) | 2.12650304 |
97 | Megaloblastic anemia (HP:0001889) | 2.10745333 |
98 | Impaired vibratory sensation (HP:0002495) | 2.07566502 |
99 | Spastic gait (HP:0002064) | 2.06377546 |
100 | Genetic anticipation (HP:0003743) | 2.05551449 |
101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05189298 |
102 | Absent/shortened dynein arms (HP:0200106) | 2.05189298 |
103 | Genital tract atresia (HP:0001827) | 2.04067360 |
104 | Neurofibrillary tangles (HP:0002185) | 2.02362253 |
105 | Renal Fanconi syndrome (HP:0001994) | 2.01062716 |
106 | Psychosis (HP:0000709) | 2.00641265 |
107 | Abnormality of the renal medulla (HP:0100957) | 1.99780521 |
108 | Mutism (HP:0002300) | 1.99168724 |
109 | Increased CSF lactate (HP:0002490) | 1.98774766 |
110 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98493224 |
111 | Vaginal atresia (HP:0000148) | 1.96677623 |
112 | Polydipsia (HP:0001959) | 1.96434594 |
113 | Abnormal drinking behavior (HP:0030082) | 1.96434594 |
114 | Cystic liver disease (HP:0006706) | 1.96210171 |
115 | Protruding tongue (HP:0010808) | 1.95475737 |
116 | Craniofacial dystonia (HP:0012179) | 1.95416932 |
117 | Dysmetric saccades (HP:0000641) | 1.95321886 |
118 | Incomplete penetrance (HP:0003829) | 1.95277778 |
119 | Spastic tetraplegia (HP:0002510) | 1.95037121 |
120 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.94964100 |
121 | Failure to thrive in infancy (HP:0001531) | 1.94617153 |
122 | Resting tremor (HP:0002322) | 1.92620186 |
123 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92351327 |
124 | Medial flaring of the eyebrow (HP:0010747) | 1.91830771 |
125 | Synostosis involving the elbow (HP:0003938) | 1.91598513 |
126 | Humeroradial synostosis (HP:0003041) | 1.91598513 |
127 | Hypoventilation (HP:0002791) | 1.90928873 |
128 | Abolished electroretinogram (ERG) (HP:0000550) | 1.90667918 |
129 | Congenital primary aphakia (HP:0007707) | 1.89555174 |
130 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.87168928 |
131 | Esotropia (HP:0000565) | 1.87136503 |
132 | Ulnar claw (HP:0001178) | 1.86499822 |
133 | Optic nerve hypoplasia (HP:0000609) | 1.86478450 |
134 | Tachypnea (HP:0002789) | 1.85347034 |
135 | Methylmalonic acidemia (HP:0002912) | 1.84710784 |
136 | Hyperthyroidism (HP:0000836) | 1.83922459 |
137 | Optic disc pallor (HP:0000543) | 1.83713961 |
138 | Abnormality of the corticospinal tract (HP:0002492) | 1.83663065 |
139 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.82235838 |
140 | Hypoplasia of the fovea (HP:0007750) | 1.81488824 |
141 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.81488824 |
142 | Blue irides (HP:0000635) | 1.80936687 |
143 | Abnormality of urine glucose concentration (HP:0011016) | 1.80919312 |
144 | Glycosuria (HP:0003076) | 1.80919312 |
145 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78579161 |
146 | Methylmalonic aciduria (HP:0012120) | 1.78102826 |
147 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77925070 |
148 | Lower limb muscle weakness (HP:0007340) | 1.77593755 |
149 | Abnormality of salivation (HP:0100755) | 1.77506283 |
150 | Hypomagnesemia (HP:0002917) | 1.77187973 |
151 | Gait ataxia (HP:0002066) | 1.77088620 |
152 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.76827975 |
153 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.76827975 |
154 | Generalized aminoaciduria (HP:0002909) | 1.76167165 |
155 | Specific learning disability (HP:0001328) | 1.74942233 |
156 | Conical tooth (HP:0000698) | 1.74540749 |
157 | Rapidly progressive (HP:0003678) | 1.74294085 |
158 | Severe muscular hypotonia (HP:0006829) | 1.74081824 |
159 | Akinesia (HP:0002304) | 1.73860062 |
160 | Abnormality of the fovea (HP:0000493) | 1.73116173 |
161 | Hypoalbuminemia (HP:0003073) | 1.73099897 |
162 | Abnormal albumin level (HP:0012116) | 1.73099897 |
163 | Hepatocellular necrosis (HP:0001404) | 1.72794719 |
164 | Thickened helices (HP:0000391) | 1.72786634 |
165 | Abnormality of eosinophils (HP:0001879) | 1.72100308 |
166 | Nephrogenic diabetes insipidus (HP:0009806) | 1.71984912 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.15586876 |
2 | NTRK3 | 4.51088181 |
3 | MAP3K9 | 3.40217762 |
4 | MAP3K12 | 3.28994895 |
5 | CASK | 3.24515569 |
6 | TLK1 | 3.12337093 |
7 | MAP3K4 | 3.06873878 |
8 | MAP2K7 | 2.81378178 |
9 | FRK | 2.64268872 |
10 | RIPK4 | 2.58459295 |
11 | MINK1 | 2.52265019 |
12 | DAPK2 | 2.48575270 |
13 | BMPR1B | 2.40350028 |
14 | WNK3 | 2.31536354 |
15 | PLK2 | 2.30387133 |
16 | MAP4K2 | 2.17013769 |
17 | ARAF | 2.12564724 |
18 | MAP2K4 | 2.07192974 |
19 | DAPK1 | 2.04626969 |
20 | KSR2 | 1.97041908 |
21 | GRK5 | 1.94120911 |
22 | GRK1 | 1.87505056 |
23 | BCKDK | 1.86407304 |
24 | CDK19 | 1.83935022 |
25 | MARK1 | 1.80306984 |
26 | FGFR2 | 1.79862444 |
27 | KSR1 | 1.77995095 |
28 | PNCK | 1.71655171 |
29 | TRIM28 | 1.68765900 |
30 | PAK6 | 1.61068302 |
31 | NME1 | 1.55167457 |
32 | DYRK2 | 1.53593970 |
33 | CSNK1G3 | 1.46267427 |
34 | NTRK2 | 1.42658252 |
35 | MAP3K13 | 1.39179601 |
36 | PTK2B | 1.36092367 |
37 | CDK5 | 1.34999144 |
38 | OBSCN | 1.34015965 |
39 | BMPR2 | 1.33733662 |
40 | NTRK1 | 1.32304149 |
41 | PRPF4B | 1.31524042 |
42 | TNIK | 1.27744258 |
43 | PRKCG | 1.24271238 |
44 | SIK2 | 1.21529802 |
45 | CSNK1A1L | 1.21420577 |
46 | CAMK2A | 1.19811291 |
47 | MAPK13 | 1.16944740 |
48 | CSNK1G1 | 1.16052472 |
49 | INSRR | 1.15537792 |
50 | CAMKK1 | 1.14491779 |
51 | FES | 1.14384133 |
52 | STK16 | 1.12341759 |
53 | RAF1 | 1.10552597 |
54 | CAMKK2 | 1.07615771 |
55 | MUSK | 1.06569789 |
56 | PRKD3 | 1.04944814 |
57 | OXSR1 | 1.04780863 |
58 | ZAK | 1.02099301 |
59 | CAMK2B | 1.01321836 |
60 | PIK3CA | 1.00890056 |
61 | SIK3 | 1.00432111 |
62 | FGR | 0.96475013 |
63 | MAP2K6 | 0.96208211 |
64 | MAP3K2 | 0.93303506 |
65 | CCNB1 | 0.93137097 |
66 | CDK18 | 0.90751525 |
67 | LIMK1 | 0.90533057 |
68 | TAOK3 | 0.89622382 |
69 | UHMK1 | 0.87439480 |
70 | ERBB3 | 0.86487589 |
71 | CDK14 | 0.84642912 |
72 | CDK15 | 0.84232203 |
73 | IRAK4 | 0.77655692 |
74 | BRAF | 0.77581379 |
75 | CDK11A | 0.73728466 |
76 | SGK494 | 0.73531000 |
77 | SGK223 | 0.73531000 |
78 | GRK6 | 0.72782484 |
79 | RPS6KA5 | 0.72354731 |
80 | CSNK1A1 | 0.71681328 |
81 | MAPK15 | 0.71228509 |
82 | CAMK1 | 0.70160878 |
83 | STK38 | 0.69736525 |
84 | GRK7 | 0.69226659 |
85 | BCR | 0.68912055 |
86 | DYRK1A | 0.67296602 |
87 | AKT3 | 0.65771309 |
88 | TYRO3 | 0.63343788 |
89 | PRKCI | 0.63264253 |
90 | TIE1 | 0.60390251 |
91 | SGK1 | 0.59592608 |
92 | PRKCE | 0.59243421 |
93 | MAP3K6 | 0.58606941 |
94 | DAPK3 | 0.57953475 |
95 | MAPKAPK5 | 0.57147610 |
96 | PIM2 | 0.56923386 |
97 | SGK2 | 0.56376224 |
98 | PAK3 | 0.56195192 |
99 | PKN1 | 0.55600662 |
100 | LATS2 | 0.55536638 |
101 | STK11 | 0.55298478 |
102 | CSNK1D | 0.54761577 |
103 | CAMK2D | 0.53274618 |
104 | CSNK1G2 | 0.53050696 |
105 | MAP3K1 | 0.52966663 |
106 | PDPK1 | 0.52759342 |
107 | CAMK2G | 0.52652623 |
108 | FGFR1 | 0.52208146 |
109 | RET | 0.51631406 |
110 | MAP3K11 | 0.51405842 |
111 | PDK1 | 0.51334426 |
112 | ADRBK1 | 0.50400201 |
113 | MAP2K1 | 0.50399260 |
114 | PRKCH | 0.48426907 |
115 | FER | 0.47842153 |
116 | TGFBR1 | 0.46264634 |
117 | MARK2 | 0.44971863 |
118 | MAPKAPK3 | 0.43643874 |
119 | TNK2 | 0.43035060 |
120 | PHKG2 | 0.42568689 |
121 | PHKG1 | 0.42568689 |
122 | MOS | 0.41650927 |
123 | WNK4 | 0.41180765 |
124 | TAOK1 | 0.41079756 |
125 | DYRK3 | 0.41077962 |
126 | ADRBK2 | 0.40602481 |
127 | PLK1 | 0.39456201 |
128 | PRKCZ | 0.39373497 |
129 | NUAK1 | 0.38128421 |
130 | ROCK2 | 0.37614093 |
131 | PRKACB | 0.37132147 |
132 | ACVR1B | 0.36339451 |
133 | PINK1 | 0.35098569 |
134 | PRKACA | 0.34114263 |
135 | RPS6KA3 | 0.33446006 |
136 | MAP2K2 | 0.33429630 |
137 | PRKAA1 | 0.32572227 |
138 | MAPK12 | 0.30825522 |
139 | PRKG1 | 0.30651904 |
140 | FYN | 0.30472187 |
141 | TSSK6 | 0.30236984 |
142 | PRKCA | 0.29949525 |
143 | STK39 | 0.29274671 |
144 | SGK3 | 0.29207797 |
145 | MYLK | 0.28977339 |
146 | PDK3 | 0.28499246 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.99844881 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.70400554 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.86159786 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.85687350 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72534267 |
6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.68592300 |
7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.66363939 |
8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.63990011 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62800627 |
10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.60458851 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.56512509 |
12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.53313899 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 2.52111055 |
14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.49194905 |
15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44422628 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.41194121 |
17 | Sulfur relay system_Homo sapiens_hsa04122 | 2.39478123 |
18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.26734715 |
19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.24510933 |
20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.22913674 |
21 | Salivary secretion_Homo sapiens_hsa04970 | 2.19549201 |
22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07031163 |
23 | Taste transduction_Homo sapiens_hsa04742 | 2.00299633 |
24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87956902 |
25 | Insulin secretion_Homo sapiens_hsa04911 | 1.86601147 |
26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84525994 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.82241972 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.77168287 |
29 | Long-term depression_Homo sapiens_hsa04730 | 1.75251890 |
30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73152727 |
31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.71363770 |
32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.68042169 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67761482 |
34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66306994 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65310552 |
36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.64860252 |
37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63295624 |
38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61364242 |
39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61177277 |
40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58368042 |
41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56057345 |
42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49710056 |
43 | Protein export_Homo sapiens_hsa03060 | 1.48945221 |
44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46261814 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43713574 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37822368 |
47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35944241 |
48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30657903 |
49 | Gap junction_Homo sapiens_hsa04540 | 1.28897403 |
50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25788798 |
51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23136893 |
52 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17794927 |
53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17073703 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13569393 |
55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12916823 |
56 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10589230 |
57 | Phototransduction_Homo sapiens_hsa04744 | 1.06889512 |
58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05272538 |
59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01552141 |
60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00106106 |
61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99907214 |
62 | Melanogenesis_Homo sapiens_hsa04916 | 0.95771721 |
63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95603519 |
64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93525961 |
65 | Axon guidance_Homo sapiens_hsa04360 | 0.92615155 |
66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91632120 |
67 | Glioma_Homo sapiens_hsa05214 | 0.90324948 |
68 | Mineral absorption_Homo sapiens_hsa04978 | 0.90212638 |
69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87012406 |
70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82681679 |
71 | Peroxisome_Homo sapiens_hsa04146 | 0.81849946 |
72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80348163 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79790610 |
74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79698772 |
75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78867541 |
76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78463938 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76992609 |
78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76373763 |
79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73191300 |
80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72739275 |
81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70509432 |
82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69776813 |
83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67505239 |
84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.64924526 |
85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64814103 |
86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63930637 |
87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62632184 |
88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61504197 |
89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61052656 |
90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60004744 |
91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58219393 |
92 | ABC transporters_Homo sapiens_hsa02010 | 0.57200337 |
93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56788938 |
94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56121363 |
95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55937955 |
96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54571863 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54555581 |
98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53948206 |
99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53766657 |
100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53163832 |
101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52272275 |
102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52052289 |
103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51872607 |
104 | RNA polymerase_Homo sapiens_hsa03020 | 0.51473755 |
105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50124895 |
106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48820964 |
107 | Alcoholism_Homo sapiens_hsa05034 | 0.48337498 |
108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47515823 |
109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45359793 |
110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44800038 |
111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44528836 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44157936 |
113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43643057 |
114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41948027 |
115 | Ribosome_Homo sapiens_hsa03010 | 0.41215954 |
116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40961124 |
117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40264523 |
118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39904964 |
119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39190704 |
120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36934350 |
121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36667535 |
122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36530992 |
123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35342614 |
124 | Prion diseases_Homo sapiens_hsa05020 | 0.35267925 |
125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34736233 |
126 | Phagosome_Homo sapiens_hsa04145 | 0.33742163 |
127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33486472 |
128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33245761 |
129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33067668 |
130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32417387 |
131 | Proteasome_Homo sapiens_hsa03050 | 0.31252762 |
132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30947186 |
133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29330394 |
134 | RNA degradation_Homo sapiens_hsa03018 | 0.27433338 |
135 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.26654509 |
136 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25367547 |
137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24719099 |
138 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23680105 |
139 | Endocytosis_Homo sapiens_hsa04144 | 0.21446090 |
140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21163904 |
141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20619203 |
142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20460492 |
143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19808739 |
144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19514141 |
145 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18992993 |
146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17895439 |
147 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.17503515 |
148 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16728783 |
149 | Bile secretion_Homo sapiens_hsa04976 | 0.16672408 |
150 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15679916 |